
- /
- Supported exchanges
- / US
- / BLFS.NASDAQ
BioLife Solutions Inc (BLFS NASDAQ) stock market data APIs
BioLife Solutions Inc Financial Data Overview
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get BioLife Solutions Inc data using free add-ons & libraries
Get BioLife Solutions Inc Fundamental Data
BioLife Solutions Inc Fundamental data includes:
- Net Revenue: 87 762 K
- EBITDA: -455 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-07
- EPS/Forecast: -0.035
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BioLife Solutions Inc News

E2open Parent, Mission Produce See Activist Action
13D FILINGS Original Filings E2open Parent Holdings (ETWO) Magnetar Financial disclosed a new position in the supply-chain tech firm of 16,653,039 shares. Magnetar Financial purchased those shares fro...


H.C. Wainwright Maintains Buy rating on BioLife (BLFS) Stock
On May 27, H.C. Wainwright reaffirmed its Buy rating on BioLife Solutions, Inc. (NASDAQ:BLFS) while keeping the price target the same at $30. The bullish sentiment comes after the firm adjusted its fi...

Merit Medical acquires haemostatic device manufacturer Biolife for $120m
Merit Medical Systems has acquired US-based Biolife Delaware, a manufacturer of haemostatic devices, in a $120m deal. The transaction value was paid in cash alongside the assumption of Biolife's liab...

Strength Seen in Insulet (PODD): Can Its 7.2% Jump Turn into More Strength?
Insulet PODD shares soared 7.2% in the last trading session to close at $264.72. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.